60 Degrees Pharmaceuticals Accounts Payable

60 Degrees Pharmaceuticals (SXTP) currently reports a accounts payable of $0 as of June 2026. That compares with $910K in the prior-year period — down 100.0% year over year. Use the charts on this page to explore 60 Degrees Pharmaceuticals's accounts payable history and peer comparisons.

60 Degrees Pharmaceuticals's accounts payable decreased from $910K to $0 — a 100.0% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

60 Degrees Pharmaceuticals reported $0 in accounts payable as of June 2026. That compares with $910K in the prior-year period — down 100.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current accounts payable of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for 60 Degrees Pharmaceuticals, and consider following SXTP for alerts when major investors trade the stock.